Compare BridgeBio Pharma Inc (BBIO) vs IONQ Inc (IONQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs IONQ Inc — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.61B), while IONQ Inc trades at $44.04 (market cap $17.23B). The key difference: BridgeBio Pharma Inc and IONQ Inc are close in size by market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, IONQ Inc nearer its low. Which is the better fit depends on your goals.
| BBIO | IONQ | |
|---|---|---|
Market Cap | $16.61B | $17.23B |
Sector | Health | Technology |
52-Week High | $90.17 | $82.09 |
52-Week Low | $47.29 | $26.59 |
Enterprise Value | $18.16B | $15.17B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
IONQ stock trades at $44.43, up 11.86% in 24 hours, with a bullish technical signal and strong revenue growth of 287% year-over-year in Q2 2026. The company reported a Q2 EPS miss but revenue beat, raised its 2026 outlook, and secured a $28 million defense contract. Valuation ratios are elevated with a P/E of 102.38 and P/S of 59.02, while profitability remains negative with a net income margin of -553.27% in 2026.
Outlook is optimistic due to quantum computing demand and analyst consensus price target of $73.33, but risks include high cash burn, intense competition, and reliance on speculative technology. Investors should weigh growth potential against persistent losses and dilution concerns from recent share issuance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About IONQ Inc
IonQ is a leader in quantum computing, developing world-class quantum systems. Its technology aims to solve complex problems across finance, healthcare, and materials science that are beyond classical computers.
Read more on IONQ →
